Jushi Holdings (JUSHF) Acquisitions (2021 - 2022)

Jushi Holdings (JUSHF) posted quarterly Acquisitions of $86000.0 for Q4 2022, up 26.47% quarter-over-quarter from $68000.0 in Q3 2022.

Jushi Holdings (JUSHF) Acquisitions (2021 - 2022) Analysis & Trends

Jushi Holdings (JUSHF) has reported Acquisitions for 2 consecutive years, with $86000.0 the latest figure, recorded in Q4 2022.

In Q4 2022, Acquisitions changed N/A year-over-year to $86000.0; the TTM figure through Sep 2023 stood at $86000.0 (down 99.59% YoY), while the FY2022 annual figure was $21.0 million, down 55.66% from the prior year.
Acquisitions grew to $86000.0 in Q4 2022 per JUSHF's latest filing, from $68000.0 in the prior quarter.
Across five years, Acquisitions topped out at $42.1 million in Q3 2021 and bottomed at $68000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-	-
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn	-
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	-
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	-
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	-
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-	-
10	Jushi Holdings	83.87 Mn	50.54 Mn	31.53 Mn	-

Download Data